John C. Drach

7.0k total citations
233 papers, 5.8k citations indexed

About

John C. Drach is a scholar working on Epidemiology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, John C. Drach has authored 233 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Epidemiology, 100 papers in Organic Chemistry and 69 papers in Molecular Biology. Recurrent topics in John C. Drach's work include Cytomegalovirus and herpesvirus research (94 papers), Biochemical and Molecular Research (48 papers) and HIV/AIDS drug development and treatment (48 papers). John C. Drach is often cited by papers focused on Cytomegalovirus and herpesvirus research (94 papers), Biochemical and Molecular Research (48 papers) and HIV/AIDS drug development and treatment (48 papers). John C. Drach collaborates with scholars based in United States, Poland and Germany. John C. Drach's co-authors include Leroy B. Townsend, Charles Shipman, Steven R. Turk, Rodrigo V. Devivar, Karen K. Biron, Sandra H. Smith, Mahmoud Nassiri, Jiří Žemlička, Earl R. Kern and Roger G. Ptak and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

John C. Drach

230 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John C. Drach United States 40 2.5k 2.4k 1.5k 1.1k 1.1k 233 5.8k
Leroy B. Townsend United States 43 3.9k 1.6× 1.9k 0.8× 3.2k 2.1× 854 0.8× 1.2k 1.1× 343 7.7k
Richard R. Tidwell United States 48 2.6k 1.1× 2.3k 0.9× 1.7k 1.1× 404 0.4× 1.0k 0.9× 160 6.0k
Jacob J. Plattner United States 34 2.3k 0.9× 699 0.3× 2.1k 1.4× 377 0.3× 989 0.9× 113 4.8k
Patrick G. Bray United Kingdom 42 1.1k 0.5× 573 0.2× 1.1k 0.7× 870 0.8× 826 0.8× 80 4.5k
Chung K. Chu United States 41 2.6k 1.0× 1.4k 0.6× 2.9k 1.9× 307 0.3× 3.0k 2.7× 219 6.1k
Thomas A. Krenitsky United States 40 483 0.2× 1.5k 0.6× 3.3k 2.2× 622 0.6× 1.3k 1.2× 96 5.0k
Jan Balzarini Belgium 46 2.7k 1.1× 1.4k 0.6× 3.8k 2.5× 689 0.6× 2.2k 2.0× 213 7.6k
P de Miranda United States 35 520 0.2× 3.5k 1.4× 1.2k 0.8× 925 0.8× 1.3k 1.2× 68 5.5k
Phillip A. Furman United States 34 735 0.3× 2.7k 1.1× 1.6k 1.0× 387 0.3× 2.3k 2.1× 73 5.3k
Jiří Žemlička United States 30 1.3k 0.5× 709 0.3× 1.4k 0.9× 374 0.3× 784 0.7× 190 3.0k

Countries citing papers authored by John C. Drach

Since Specialization
Citations

This map shows the geographic impact of John C. Drach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Drach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Drach more than expected).

Fields of papers citing papers by John C. Drach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Drach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Drach. The network helps show where John C. Drach may publish in the future.

Co-authorship network of co-authors of John C. Drach

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Drach. A scholar is included among the top collaborators of John C. Drach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Drach. John C. Drach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bogner, Elke, et al.. (2018). Targeting the terminase: An important step forward in the treatment and prophylaxis of human cytomegalovirus infections. Antiviral Research. 161. 116–124. 33 indexed citations
2.
Li, Chengwei, Debra C. Quenelle, Mark N. Prichard, John C. Drach, & Jiří Žemlička. (2012). Synthesis and antiviral activity of 6-deoxycyclopropavir, a new prodrug of cyclopropavir. Bioorganic & Medicinal Chemistry. 20(8). 2669–2674. 8 indexed citations
3.
Peterson, Larryn W., Jae‐Seung Kim, John M. Hilfinger, et al.. (2011). Synthesis, transport and antiviral activity of Ala–Ser and Val–Ser prodrugs of cidofovir. Bioorganic & Medicinal Chemistry Letters. 21(13). 4045–4049. 10 indexed citations
4.
Jackson, Trachette L., et al.. (2010). Phosphorylation of antiviral and endogenous nucleotides to di- and triphosphates by guanosine monophosphate kinase. Biochemical Pharmacology. 81(1). 43–49. 28 indexed citations
5.
Shen, Wei, Jae‐Seung Kim, Phillip E. Kish, et al.. (2008). Design and synthesis of vidarabine prodrugs as antiviral agents. Bioorganic & Medicinal Chemistry Letters. 19(3). 792–796. 34 indexed citations
6.
Less, Gregory B., N.W. Ockwig, Paul G. Rasmussen, et al.. (2006). Vanadium Complex of 2-(2‘-Pyridyl)-4,5-dicyanoimidazole Showing Spermicidal and Cytotoxic Properties. Inorganic Chemistry. 45(18). 7105–7110. 11 indexed citations
7.
Eriksson, Ulrika, John M. Hilfinger, Jae‐Seung Kim, et al.. (2006). Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir. Bioorganic & Medicinal Chemistry Letters. 17(3). 583–586. 14 indexed citations
8.
Shin, Ho‐Chul, et al.. (2006). Interaction of Intestinal Nucleoside Transporter hCNT2 with Amino Acid Ester Prodrugs of Floxuridine and 2-Bromo-5,6-dichloro-1-.BETA.-D-ribofuranosylbenzimidazole. Biological and Pharmaceutical Bulletin. 29(2). 247–252. 6 indexed citations
9.
Williams, John D., John C. Drach, & Leroy B. Townsend. (2004). Synthesis and Antiviral Evaluation of Some Novel Tricyclic Pyrazolo[3,4‐b]indole Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 23(5). 805–812. 7 indexed citations
10.
Porcari, Anthony R., Roger G. Ptak, Katherine Z. Borysko, et al.. (2003). Synthesis and Antiviral Activity of 2-Substituted Analogs of Triciribine. Nucleosides Nucleotides & Nucleic Acids. 22(12). 2171–2193. 5 indexed citations
11.
Zou, Ruiming, Etsuko Kawashima, George A. Freeman, et al.. (2000). Design, Synthesis, and Antiviral Evaluation of 2-Deoxy-D-Ribosides of Substituted Benzimidazoles as Potential Agents for Human Cytomegalovirus Infections. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 125–153. 14 indexed citations
12.
Krawczyk, Steven H., Michael T. Migawa, John C. Drach, & Leroy B. Townsend. (2000). Synthesis of 4-Substituted Imidazo[4,5-d][1,2,3]triazine (2-Azapurine)nucleosides. Nucleosides Nucleotides & Nucleic Acids. 19(1-2). 39–68. 6 indexed citations
13.
Chulay, Jeffrey D., Karen K. Biron, Mark Underwood, et al.. (1999). Development of Novel Benzimidazole Riboside Compounds for Treatment of Cytomegalovirus Disease. Advances in experimental medicine and biology. 458. 129–134. 39 indexed citations
14.
KRAWCZYK, S. H., Mahmoud Nassiri, Louis S. Kucera, et al.. (1995). Synthesis and Antiproliferative and Antiviral Activity of 2'-Deoxy-2'-fluoroarabinofuranosyl Analogs of the Nucleoside Antibiotics Toyocamycin and Sangivamycin. Journal of Medicinal Chemistry. 38(20). 4106–4114. 37 indexed citations
15.
16.
Kucera, Louis S., Shelby Puckett, Robert W. Buckheit, et al.. (1993). Activity of Triciribine and Triciribine-5′ -Monophosphate Against Human Immunodeficiency Virus Types 1 and 2. AIDS Research and Human Retroviruses. 9(4). 307–314. 15 indexed citations
17.
Nassiri, Mahmoud, et al.. (1989). Synthesis, cytotoxicity, and antiviral activity of certain 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidine nucleosides related to toyocamycin and sangivamycin. Journal of Medicinal Chemistry. 32(7). 1420–1425. 39 indexed citations
18.
Saxena, Neeraj K., et al.. (1988). Synthesis and antiviral activity of certain 4-substituted and 2,4-disubstituted 7-[(2-hydroxyethoxy)methyl]pyrrolo[2,3-d]pyrimidines. Journal of Medicinal Chemistry. 31(8). 1501–1506. 27 indexed citations
19.
Turk, Steven R., et al.. (1987). Inhibition of herpes simplex virus DNA replication by ara-tubercidin. Antiviral Research. 8(2). 97–102. 3 indexed citations
20.
Lipper, Robert A., et al.. (1978). Inhibition of Drug Metabolism by a Prodrug: 9-β-D-Arabinofuranosyladenine 5'-Valerate as an Inhibitor of Adenosine Deaminase. Molecular Pharmacology. 14(2). 366–369. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leroy B. Townsend Breakdown of academic impact, for papers by Richard R. Tidwell Breakdown of academic impact, for papers by Jacob J. Plattner Breakdown of academic impact, for papers by Patrick G. Bray Breakdown of academic impact, for papers by Chung K. Chu Breakdown of academic impact, for papers by Thomas A. Krenitsky Breakdown of academic impact, for papers by Jan Balzarini Breakdown of academic impact, for papers by P de Miranda Breakdown of academic impact, for papers by Phillip A. Furman Breakdown of academic impact, for papers by Jiří Žemlička
Rankless by CCL
2026